About US
Contact us
-
Bristol Myers Squibb hands pink slips to 195 workers in New Jersey as cost-cutting effort rolls onBristol Myers Squibb has executed another round of layoffs in its ongoing cost-savings push. The company has handed pink slips to 195 more employees, according to a New Jersey Worker Adjustment and R2024/11/26
-
Merck preps filings after blockbuster-in-waiting Winrevair succeeds in severe PAH studyEight months after snaring an inaugural FDA green light, Merck & Co. is bolstering the case for the chief asset in its $11.5 billion Acceleron acquisition. In the phase 3 ZENITH study, Merck’s ac2024/11/26
-
Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for top FDA job: reportsWhile President-elect Donald Trump has already made his leadership picks for the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS), a crucial sp2024/11/21
-
Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and Daiichi's EnhertuA bispecific antibody has entered the HER2 fray with a differentiated profile from traditional agents and a chance to challenge AstraZeneca and Daiichi Sankyo’s star antibody-drug conjugate Enhertu.2024/11/21
-
Johnson & Johnson, Merck lay off workers in China as local headwinds take a tollJohnson & Johnson and Merck arelaying offworkers in China, according to a story from Bloomberg which cites reports from Chinese news outlets and confirmation from industry sources in the country.2024/11/19
-
Rapid growth spurt for UCB's Bimzelx continues with hidradenitis suppurativa nod marking 5th FDA approvalIt was only last October that UCB’s up-and-coming immunology powerhouse Bimzelx first crossed the FDA finish line in psoriasis after an initial delay. Now with a new nod in hidradenitis suppurativa (2024/11/19
-
With high hopes for the economy, AstraZeneca adds $2B to US investment in manufacturing, R&DCiting a rosy view of the U.S. economy’s potential for growth over the next several years, British Big Pharma AstraZeneca is substantially boosting its investment in manufacturing and R&D in the2024/11/15
-
Pfizer explores sale of hospital drugs unit amid activist investor's call for accountability: ReutersAfter a series of acquisitions and an activist investor’s accusation of overspending, Pfizer is exploring an opportunity to slim down by divesting its hospital drugs unit,Reuters reports, citing peop2024/11/15
-
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: LeerinkAs a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in acquiring external products with the potential to launch in the near term. Me2024/11/12
-
After election, FDA's Califf lays out hopes for his Trump-appointed successorWhile personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the qualities that he hopes his successor will have. “I think ability to funct2024/11/12